NCT02981485

Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Peking Union Medical College · Academic / Other
• Sex: Female
• Age: 20 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Breast cancer related lymphedema (BRCL) is a common complication following breast cancer treatment. The incidence of BRCL ranges from 6-50%, depending on the surgical procedure in the axilla and the type of the radiation therapy. BRCL can causes cosmetic deformities, impaired physical mobility, mental discomfort, reduced quality of life and erysipelas. Therapy of BRCL is divided into conservative and operative methods. However, all the above method has some shortcomings. It is urgent to investigate new approaches to treat BRCL. In this study, fat grafting is to be used for the treatment of BRCL, and the efficacy and safety of this method will be also assessed.

Conditions

• Breast Cancer Lymphedema

Interventions

Type	Name	Description
DEVICE	Fat Grafting	Treatment of breast cancer related lymphedema by fat grafting

Timeline

• Start date: 2016-12-01
• Primary completion: 2018-01-01
• Completion: 2019-01-01
• First posted: 2016-12-05
• Last updated: 2016-12-06

Locations

1 site across 1 country: China